National Health Investors (NYSE:NHI) Coverage Initiated by Analysts at Huntington

Key Points

• Huntington initiated coverage of National Health Investors with an “outperform” rating and a $79 price target, implying 12.68% upside from the stock’s current level. Analysts overall maintain a “Moderate Buy” consensus with an average target of $82.25.
• NHI shares opened at $70.11, down 1.8%, and remain below their 50-day and 200-day moving averages. The REIT reported quarterly EPS of $1.19 on $121.32 million in revenue, while maintaining fiscal 2026 EPS guidance of $4.74–$4.79.
• Institutional ownership is substantial at 62.51%, with major new or expanded positions from BlackRock, California State Teachers Retirement System, Bank of New York Mellon, Bank of America, and Norges Bank. A company director also purchased 890 shares at an average price of $71.65.

Equities researchers at Huntington started coverage on shares of National Health Investors (NYSE:NHI - Get Free Report) in a note issued to investors on Thursday, Briefing.com reports. The firm set an "outperform" rating and a $79.00 price target on the real estate investment trust's stock. Huntington's price objective would suggest a potential upside of 12.68% from the company's current price.

A number of other research firms have also weighed in on NHI. National Bank Financial set a $79.00 price target on National Health Investors in a research report on Wednesday. Zacks Research downgraded National Health Investors from a "hold" rating to a "strong sell" rating in a research note on Thursday, June 25th. Truist Financial decreased their price objective on National Health Investors from $81.00 to $80.00 and set a "buy" rating for the company in a research report on Wednesday, September 2nd. BMO Capital Markets lowered their target price on National Health Investors from $90.00 to $80.00 and set an "outperform" rating on the stock in a research note on Monday, June 15th. Finally, Weiss Ratings downgraded National Health Investors from a "buy (b)" rating to a "buy (b-)" rating in a report on Friday, June 12th. Six analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $82.25.

National Health Investors Stock Down 1.8%

NHI opened at $70.11 on Thursday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78. The company has a market capitalization of $3.44 billion, a PE ratio of 20.26, a P/E/G ratio of 3.81 and a beta of 0.52. The stock's fifty day moving average is $75.02 and its 200-day moving average is $77.73. National Health Investors has a one year low of $67.94 and a one year high of $91.38.

National Health Investors (NYSE:NHI - Get Free Report) last announced its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. The business had revenue of $121.32 million during the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The company's quarterly revenue was up 1.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, equities analysts predict that National Health Investors will post 4.76 EPS for the current fiscal year.

Insider Buying and Selling at National Health Investors

In other news, Director Robert A. Mccabe, Jr. acquired 890 shares of the business's stock in a transaction that occurred on Monday, June 15th. The stock was acquired at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the acquisition, the director owned 44,159 shares in the company, valued at approximately $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 2.70% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. BlackRock Inc. bought a new stake in National Health Investors in the second quarter worth approximately $665,997,000. California State Teachers Retirement System raised its holdings in shares of National Health Investors by 7,748.8% during the 2nd quarter. California State Teachers Retirement System now owns 4,077,393 shares of the real estate investment trust's stock valued at $310,942,000 after purchasing an additional 4,025,444 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of National Health Investors in the 2nd quarter valued at $122,509,000. Bank of America Corp DE acquired a new stake in shares of National Health Investors in the 2nd quarter valued at $77,738,000. Finally, Norges Bank bought a new stake in National Health Investors in the fourth quarter worth $55,301,000. Hedge funds and other institutional investors own 62.51% of the company's stock.

About National Health Investors

National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.